当前地点：
选择地点：
2023/09/26
SINOVAC Reports Unaudited First Half of 2023 Financial Results
2023/05/01
2022 Annual Report
Second Half of 2022 Financial Report
2023/09/12
SINOVAC Reports on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 Injection
2023/09/05
Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer
2021/12/30
Report of foreign issuer [Rules 13a-16 and 15d-16]
EN
